Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Disease Progression in Genetically Defined Subjects With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

NCT03894020 is registered in ClinicalTrials.gov with Gyroscope Therapeutics Limited as lead sponsor.

NCT NCT03894020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Disease Progression in Genetically Defined Subjects With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Lead sponsor
Gyroscope Therapeutics Limited
Phase
Observational
Overall status
Terminated
Start date
January 8, 2019
Completion date
March 25, 2024
Enrollment
83 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

dry age-related macular degeneration, geographic atrophy, macular atrophy, macular degeneration, retinal degeneration, retinal disease